This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. This pilot project mechanism is modeled after internal grant mechanisms at WVU that are peer-reviewed and require adequate progress and external grant submissions after completion. The CoBRE phase III will support three multi-disciplinary and highly innovative projects at $50,000 per year in year 1, followed by two projects at $50,000 per year in year 2 and one project per year in subsequent years. Grants can be renewable for up to one year, but only on a competitive basis, with significant progress expected in year 1 for renewal. Multi-investigator applications that work across several disciplines to answer significant biological questions in a unique manner will be given highest priority. Applicants are expected to utilize technologies available in the CoBRE-supported core facilities. Review of applications will be performed by CN investigators, along with other WVU investigators with relevant expertise, who have previous external grant review experience. Progress reports will be evaluated at approximately the six-month progress time by the CoBRE PI and external advisors and a subset of members of the grant review committee.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
West Virginia University
Schools of Medicine
United States
Zip Code
Nichols, Cody E; Shepherd, Danielle L; Knuckles, Travis L et al. (2015) Cardiac and mitochondrial dysfunction following acute pulmonary exposure to mountaintop removal mining particulate matter. Am J Physiol Heart Circ Physiol 309:H2017-30
Thapa, Dharendra; Nichols, Cody E; Lewis, Sara E et al. (2015) Transgenic overexpression of mitofilin attenuates diabetes mellitus-associated cardiac and mitochondria dysfunction. J Mol Cell Cardiol 79:212-23
Hindman, Bridget; Goeckeler, Zoe; Sierros, Kostas et al. (2015) Non-Muscle Myosin II Isoforms Have Different Functions in Matrix Rearrangement by MDA-MB-231 Cells. PLoS One 10:e0131920
Armstead, Andrea L; Arena, Christopher B; Li, Bingyun (2014) Exploring the potential role of tungsten carbide cobalt (WC-Co) nanoparticle internalization in observed toxicity toward lung epithelial cells in vitro. Toxicol Appl Pharmacol 278:1-8
Sinha, Satyabrata; Belcastro, Marycharmain; Datta, Poppy et al. (2014) Essential role of the chaperonin CCT in rod outer segment biogenesis. Invest Ophthalmol Vis Sci 55:3775-85
Gao, Xueli; Sinha, Satyabrata; Belcastro, Marycharmain et al. (2013) Splice isoforms of phosducin-like protein control the expression of heterotrimeric G proteins. J Biol Chem 288:25760-8
Pistilli, Emidio E; Guo, Ge; Stauber, William T (2013) IL-15R? deficiency leads to mitochondrial and myofiber differences in fast mouse muscles. Cytokine 61:41-5
Zhang, Na; Zhang, Lijuan; Qiu, Bensheng et al. (2012) Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging 36:355-63
Marrs, Glen S; Spirou, George A (2012) Embryonic assembly of auditory circuits: spiral ganglion and brainstem. J Physiol 590:2391-408
Belcastro, Marycharmain; Song, Hongman; Sinha, Satyabrata et al. (2012) Phosphorylation of phosducin accelerates rod recovery from transducin translocation. Invest Ophthalmol Vis Sci 53:3084-91

Showing the most recent 10 out of 13 publications